Tonix Pharmaceuticals Holding Corp. (TNXP) Files Form 4 Insider Buying : Seth Lederman Buys 25,000 Shares

Tonix Pharmaceuticals Holding Corp. (TNXP): Seth Lederman , CEO of Tonix Pharmaceuticals Holding Corp. purchased 25,000 shares on Jun 21, 2016. The Insider buying transaction was reported by the company on Jun 21, 2016 to the Securities and Exchange Commission. The shares were purchased at $2.00 per share for a total value of $50,000.00 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on Jun 21, 2016, Seth Lederman (CEO) purchased 25,000 shares at $2.00 per share price.On Jun 21, 2016, John B Rhodes (director) purchased 25,000 shares at $2.00 per share price.Also, On Jun 21, 2016, Bruce Daugherty (officer ) purchased 100,000 shares at $2.00 per share price.On Jun 3, 2016, Gregory M Sullivan (Chief Medical Officer) purchased 20,000 shares at $2.50 per share price.

Shares of Tonix Pharmaceuticals Holding Corp. (TNXP) ended Monday, Jun 20, 2016 session in red amid volatile trading. The shares closed down -0.03 points or -1.52% at $1.94 with 4,97,385 shares getting traded. Post opening the session at $1.97, the shares hit an intraday low of $1.84 and an intraday high of $2.03 and the price vacillated in this range throughout the day. The company has a market cap of $37 M and the number of outstanding shares has been calculated to be 1,88,91,264 shares. The 52-week high of Tonix Pharmaceuticals Holding Corp. is $10.72 and the 52-week low is $1.84.

Tonix Pharmaceuticals Holding Corp. Money Flow Index Chart

Leave a Reply

Tonix Pharmaceuticals Holding Corp. - Is it time to Sell?

Top Brokerage Firms are advising their investors on Tonix Pharmaceuticals Holding Corp.. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.